IDEAYA Biosciences Issues Inducement Grants to New Hires

The options are priced at $36.29 per share, matching the closing market value on the date of the grant. These instruments carry a 10-year term and follow a standard four-year vesting schedule: 25% of the shares vest after the first year, with the remainder accruing in equal monthly installments over the following three years. Continued employment remains a firm requirement for the realization of these awards.

This specific equity program operates under Nasdaq Listing Rule 5635(c)(4), reserved exclusively for individuals joining the company for the first time or returning after a substantial period of non-employment. IDEAYA, which focuses on precision medicine and synthetic lethality in oncology, utilizes these inducement grants to attract specialized personnel to its drug discovery and bioinformatics teams.